Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease - Wikidata - wikimedia - TriplyDB

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease

http://www.wikidata.org/entity/Q34312272

about

Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly.Epigenomics of Alzheimer's disease.Altered expression of type-1 and type-2 cannabinoid receptors in celiac disease The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.Epigenetic control of skin differentiation genes by phytocannabinoids.CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.Epigenetic mechanisms and endocannabinoid signalling.Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque.Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.Downstream effects of endocannabinoid on blood cells: implications for health and disease.Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.Endocannabinoid system in neurodegenerative disorders.Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years.Demethylation profile of the TNF-α promoter gene is associated with high expression of this cytokine in Dengue virus patients.Decreased enteric fatty acid amide hydrolase activity is associated with colonic inertia in slow transit constipation.DNA Modifications and Alzheimer's Disease.

P2860

Q33616120-33EBC01F-6EA7-414C-B02A-2DDD3BDB357F Q34518584-6A5E34A5-3FA3-4B8C-AC30-86E401A36E83 Q34689405-927EF6B5-7B20-4E90-BA12-310C4EAFBD46 Q36223734-8415D233-164E-4F8F-B9DA-C0F6177492F1 Q36775237-15663DB2-AD69-46E8-87A5-0632BB8BB9CE Q37219086-A36D5686-F2E1-4777-A650-9E138ECCA5AC Q37446027-B0BD6FF1-C37F-4B99-95FF-C9E5236813DE Q37633222-868ABB9D-403D-4D60-99D5-A569E2B87F8A Q38072984-2B749182-B711-4CC5-82BC-5018873678DE Q38170338-FD4ECC5C-B69F-4193-903D-FE2B656A5DDE Q38196398-0C796771-08FC-4680-9ADA-23F740A27E36 Q38468985-62E77A92-B628-4B68-845B-BACA72AD8A3A Q38684679-40CBBCF8-3899-42C3-9E43-F9082AF69F5B Q39368845-3E41A075-C041-4BF2-A072-1D0FB76B7EDE Q39370805-F17C7836-28E9-45C1-BC86-282CBB119BF3 Q40121907-66B01782-BFCF-464E-9B1E-22C9FB3B5D33 Q47829257-818A9204-C1D8-4F87-BCB5-05129DC59AA5 Q48043168-AB9A5114-1454-4E4E-905C-E954A3069AF5

P2860

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease

http://www.wikidata.org/entity/Q34312272

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease

@ast

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease

@en

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease

@nl

type

label

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease

@ast

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease

@en

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease

@nl

prefLabel

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease

@ast

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease

@en

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease

@nl

P1433

Q34312272-5B8B3845-5067-47EA-956B-05CCD135A47B

P1476

Q34312272-7808C9E7-206A-44AA-8862-2B961EDB2654

P2093

Q34312272-19488CD7-D193-41AE-BCD1-55A1273E23B5

Q34312272-62A09731-6D62-471B-88E5-61E877B92369

Q34312272-8ECFC561-2FBB-4B67-9493-4DF2342CB965

Q34312272-E23713BE-A844-4465-99B6-BABB0B27F947

P2860

Q34312272-0844AAE6-2A9E-42BE-AFD7-398A61E59CD0

Q34312272-088C3F1F-25CD-4B05-A0D0-94CF2BD0C51D

Q34312272-115D9A74-A887-4EE4-9B2E-1E67562037F8

Q34312272-11FC61D5-03EB-4267-BFA9-61CF1C69959C

Q34312272-1215D5B6-3C55-4317-8A49-F1F2D28C86C8

Q34312272-1CB777B4-8F9F-4296-AD02-D1063307875C

Q34312272-26B4C19F-EBA0-49BE-8C99-A7DB079D988D

Q34312272-291DBF4B-47A5-4E3D-88BA-D2EC9555D97F

Q34312272-297FEFE5-4CE1-4210-9177-44EAB51BDC2D

Q34312272-302FD826-CD21-4D0E-A0BD-24651F40258D

P304

Q34312272-27AEA92A-69DD-49AB-84EB-7D4CAEDAE871

P31

Q34312272-6987E986-667A-444E-80EC-ACF21F606463

P356

Q34312272-D6ACAE9B-7742-46BB-BB3D-01B51526EE03

P407

Q34312272-09C2BB8C-EA8C-4E13-ABA2-F9A89D40C0A9

P433

Q34312272-50E133F7-9ACE-418B-829E-016D93600BE5

P478

Q34312272-780F8207-B144-4B38-B13D-E7341886BCCE

P50

Q34312272-166617FF-8B6F-45E6-9D69-38BAAFDB378D

Q34312272-26838C31-7E5F-4047-BC5B-952DB59D2BF6

Q34312272-3A3F8E85-CE2E-4661-94B6-9B0D7E087611

Q34312272-717A2242-B5A9-4122-BB93-7AFDA4B9B2AA

Q34312272-881C9953-68D3-4889-BE1C-6F4BA6CFB911

Q34312272-9E52544E-88CC-4EFB-B589-33868252F828

Q34312272-F6C42F9B-2A8F-45DD-B428-CCBDC1BA714C

P577

Q34312272-2CEF9D12-EB33-4FA5-B0A6-BAAC5D1B5756

P5875

Q34312272-A7CD293B-8971-4AC3-B017-0623FAA4F1ED

P698

Q34312272-895CF359-4FE0-41FC-B204-BD07ED96CB89

P921

Q34312272-4F8E437C-1F5F-4B74-BDBA-2B0AC128C8B7

Q34312272-CAD5E848-10BA-4602-8724-DFAF20AACA35

P932

Q34312272-4900FA80-09AF-4AE7-8648-474E30C72A39

P356

JOURNAL.PONE.0039186

P1433

P1476

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease

@en

P2093

A Carlo Altamura

http://www.w3.org/2001/XMLSchema#string

Andrea Di Francesco

http://www.w3.org/2001/XMLSchema#string

Cristina Gussago

http://www.w3.org/2001/XMLSchema#string

Monica Bari

http://www.w3.org/2001/XMLSchema#string

P2860

NSAIDs for the Chemoprevention of Alzheimer’s Disease

Histone deacetylases (HDACs): characterization of the classical HDAC family

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

Histone modifications, DNA methylation, and schizophrenia

Alzheimer's disease; taking the edge off with cannabinoids?

“Mini-mental state”

Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways

A simple salting out procedure for extracting DNA from human nucleated cells

Inflammation and Alzheimer's disease

Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains

P304

e39186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0039186

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Daniela Galimberti

Beatrice Arosio

Bernardo Dell'Osso

Claudio D'Addario

Mauro Maccarrone

P577

2012-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227712703

http://www.w3.org/2001/XMLSchema#string

P698

22720070

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3373611

http://www.w3.org/2001/XMLSchema#string